For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Nonrelated Party | - | - | - | 3,189,101* |
| Revenue | 1,327,733 | 7,012,633 | 6,099,889 | 6,310,142 |
| Cross Border Freight Solutions-Nonrelated Party | - | 3,552,213 | 3,733,846 | - |
| Related Party | - | - | - | 583,948* |
| Cross Border Freight Solutions-Related Party | - | 355,631 | 466,506 | - |
| Third Parties | - | - | - | 854,793* |
| Nonrelated Party-Pharmaceutical Products | - | 1,194,496 | 790,770 | - |
| Cost of revenue | 348,194 | 5,102,340 | 4,991,122 | 4,627,842 |
| Gross profit | 979,539 | 1,910,293 | 1,108,767 | 1,682,300 |
| Selling expenses | 711,553 | 903,833 | 189,411 | 235,172* |
| General and administrative expenses | 1,697,915 | 2,210,358 | 2,107,655 | 1,981,508 |
| Provision of allowance for expected credit loss on accounts receivable | 84,261 | -1,174 | 83,325 | 25,411 |
| Loss from deconsolidation of a subsidiary | - | - | - | 0* |
| Provision of allowance for credit loss on loan receivable from a third party | - | 288,000 | - | - |
| Provision of allowance for expected credit loss on loan receivable | -62,000 | - | - | - |
| Total operating expenses | 2,555,729 | 3,401,017 | 2,380,391 | 2,242,091 |
| Loss from operations | -1,576,190 | -1,490,724 | -1,271,624 | -559,791 |
| Other income, net | 103,705 | 135,541 | 146,839 | 105,396 |
| Interest expense | 26,733 | 183,449 | 196,441 | 245,016 |
| Total other income (expense) | 76,972 | -47,908 | -49,602 | -139,620 |
| Loss before income taxes | -1,499,218 | -1,538,632 | -1,321,226 | -699,411 |
| Income tax expense | 29,593 | 45,049 | 35,990 | 193,702 |
| Net loss from continuing operations | -1,528,811 | - | - | - |
| Loss from discontinued operation before the sale of abl chicago | -885,096 | - | - | - |
| Gain on sale of abl chicago | 2,556,315 | - | - | - |
| Net income (loss) from discontinued operation | 1,671,219 | - | - | - |
| Net (loss) income | 142,408 | - | - | -893,113 |
| Less net loss attributable to non-controlling interest | - | - | - | 0* |
| Net loss attributable to the company | - | -1,583,681 | -1,357,216 | -893,113 |
| Foreign currency translation income (loss) | 188,125 | 168,050 | 36,928 | -416,085.25 |
| Comprehensive income (loss) attributable to the company | 330,533 | -1,415,631 | -1,320,288 | -1,309,198.25* |
| Basic EPS | 0.01 | -0.08 | -0.09 | -0.116 |
| Diluted EPS | 0.01 | -0.08 | -0.09 | -0.116 |
| Basic Average Shares | 34,427,559 | 19,569,950 | 14,733,489 | 7,730,136 |
| Diluted Average Shares | 34,427,559 | 19,569,950 | 14,733,489 | 7,730,136 |
Lakeside Holding Ltd (LSH)
Lakeside Holding Ltd (LSH)